#Sweden #Gothenburg #Dividend #Board Members #Vitrolife AB

Vitrolife AB's Annual General Meeting: Key Resolutions Unveiled

On May 5, 2026, Vitrolife AB (publ) held its Annual General Meeting (AGM), where several significant decisions were made regarding the company's governance and financial distributions. The complete agenda was resolved in accordance with the proposals set forth by the Board and the Nomination Committee.

Board Re-elections and New Appointments

Among the most notable outcomes, the meeting saw the re-election of several existing board members, including Henrik Blomquist, Karen Lykke Sørensen, Pia Marions, and Jón Sigurdsson, who continues in his role as Chairman of the Board. The AGM also welcomed two new members to the Board: Nicklas Hansen and David T. Hansen, indicating a strategic move toward enhancing the Board's expertise and operational effectiveness.

Financial Reports and Dividend Declaration

In addition to governance changes, the AGM adopted the Income Statements and Balance Sheets for the parent and group companies. A significant decision was made to distribute a dividend of SEK 1.10 per share, which shareholders will be able to enjoy following the record date of May 7, 2026. The expected payment date for this dividend is set for May 12, 2026.

Liability Discharge and Remuneration

Another resolution made during the meeting was the discharge of Board members and the CEO from liability concerning the financial year of 2025, reinforcing the accountability framework governing the firm. The remuneration report for 2025 was also approved, determining the fees for the Board. The Chairman will receive SEK 1,350,000, while each of the other Board members will earn SEK 450,000. Additional figures were set for members of the Audit Committee and Remuneration Committee based on their respective roles.

Auditor and Incentives

The AGM resulted in the re-election of Deloitte AB to serve as Auditor until the next Annual General Meeting, with Anneli Pihl designated as the lead auditor. The remuneration for the auditing service will be paid based on approved invoices, ensuring financial propriety.

A highlight of the meeting was the approval of a long-term share incentive plan, which includes provisions for issuing and transferring warrants to participants or third parties. This initiative is aimed at aligning the interests of key personnel with those of the shareholders, fostering a culture of performance-based rewards.

Shareholder Rights and Future Plans

Importantly, the Board received authorization to resolve on new share issues during the period leading up to the next AGM. This authorization includes the option to deviate from shareholders’ preferential rights, a move that may facilitate strategic growth opportunities for the company. Furthermore, the AGM empowered the Board to buy back shares under specified conditions, reflecting a commitment to enhancing shareholder value.

Lastly, a proposal to amend the Articles of Association was accepted, aiming to update the company's governance framework in line with evolving business needs.

The AGM proceedings underscore Vitrolife AB's commitment to strategic governance, transparent financial practices, and responsive shareholder engagement. As the company navigates forward, its focus on responsible management and growth strategies will be vital in enhancing its market positioning and overall value to stakeholders.